Literature DB >> 34715746

Comparison of Fixation Methods for the Detection of Claudin 1 and E-Cadherin in Breast Cancer Cell Lines by Immunofluorescence.

Chidalu A Edechi1, Maryam Amini1,2, Mohammad K Hamedani1,2, Lucas E L Terceiro1, Barbara E Nickel3, Etienne Leygue2,4, Yvonne Myal1,5,4.   

Abstract

The tight junction membrane protein claudin 1 and the adherens junction protein E-cadherin play critical roles in cell-cell communication and in cell signaling. As a result, their protein levels and distribution in cancer have been a focus of cancer researchers in recent years. The loss of sensitivity to contact inhibition and the establishment of invasive properties in cancer are thought to be a result of the mislocalization of these membrane proteins to the cytoplasm. However, reports on their distribution and levels have been inconsistent. It is therefore critical that the techniques used to determine the cellular localization of these proteins be both consistent and reliable. This study was undertaken to determine the optimal fixation method, methanol or formalin, for the detection of claudin 1 and E-cadherin by immunofluorescence in five different human breast cancer cell lines. Both methods exhibited staining of the cell membrane and cytoplasm, but the strongest and most distinct signals were obtained using methanol fixation. Interestingly, cell-specific differences were also observed that appeared to be associated with levels of claudin 1 and E-cadherin as seen by Western blotting. Therefore, when evaluating cellular localization of the junction proteins claudin 1 and E-cadherin, expression level and cell type differences must be considered.

Entities:  

Keywords:  adherens junction proteins; breast neoplasms; epitopes; fluorescent antibody techniques; tight junction proteins

Mesh:

Substances:

Year:  2021        PMID: 34715746      PMCID: PMC8777374          DOI: 10.1369/00221554211055240

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  28 in total

1.  Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells.

Authors:  Ahmed S Sultan; Jianwu Xie; Matthew J LeBaron; Erica L Ealley; Marja T Nevalainen; Hallgeir Rui
Journal:  Oncogene       Date:  2005-01-27       Impact factor: 9.867

2.  Claudin 1 Expression Levels Affect miRNA Dynamics in Human Basal-Like Breast Cancer Cells.

Authors:  Anna Majer; Anne A Blanchard; Sarah Medina; Stephanie A Booth; Yvonne Myal
Journal:  DNA Cell Biol       Date:  2016-03-16       Impact factor: 3.311

3.  DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells.

Authors:  Andreas Eger; Kirsten Aigner; Stefan Sonderegger; Brigitta Dampier; Susanne Oehler; Martin Schreiber; Geert Berx; Amparo Cano; Hartmut Beug; Roland Foisner
Journal:  Oncogene       Date:  2005-03-31       Impact factor: 9.867

4.  Effects of short and long-term alcohol-based fixation on Sprague-Dawley rat tissue morphology, protein and nucleic acid preservation.

Authors:  Simona Panzacchi; Federica Gnudi; Daniele Mandrioli; Rita Montella; Valentina Strollo; Bruce Alexander Merrick; Fiorella Belpoggi; Eva Tibaldi
Journal:  Acta Histochem       Date:  2019-07-03       Impact factor: 2.479

5.  Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility.

Authors:  P D Leotlela; M S Wade; P H Duray; M J Rhode; H F Brown; D T Rosenthal; S K Dissanayake; R Earley; F E Indig; B J Nickoloff; D D Taub; O P Kallioniemi; P Meltzer; P J Morin; A T Weeraratna
Journal:  Oncogene       Date:  2006-12-11       Impact factor: 9.867

6.  Immunocytochemical localization of claudin-1 in the maturation ameloblasts of rat incisors.

Authors:  Sumio Nishikawa; Michio Abe
Journal:  Front Physiol       Date:  2010-11-16       Impact factor: 4.566

7.  Cadherin cytoplasmic domains inhibit the cell surface localization of endogenous E-cadherin, blocking desmosome and tight junction formation and inducing cell dissociation.

Authors:  Masayuki Ozawa; Wakako Kobayashi
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

8.  E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.

Authors:  Hisani N Horne; Hannah Oh; Mark E Sherman; Maya Palakal; Stephen M Hewitt; Marjanka K Schmidt; Roger L Milne; David Hardisson; Javier Benitez; Carl Blomqvist; Manjeet K Bolla; Hermann Brenner; Jenny Chang-Claude; Renata Cora; Fergus J Couch; Katarina Cuk; Peter Devilee; Douglas F Easton; Diana M Eccles; Ursula Eilber; Jaana M Hartikainen; Päivi Heikkilä; Bernd Holleczek; Maartje J Hooning; Michael Jones; Renske Keeman; Arto Mannermaa; John W M Martens; Taru A Muranen; Heli Nevanlinna; Janet E Olson; Nick Orr; Jose I A Perez; Paul D P Pharoah; Kathryn J Ruddy; Kai-Uwe Saum; Minouk J Schoemaker; Caroline Seynaeve; Reijo Sironen; Vincent T H B M Smit; Anthony J Swerdlow; Maria Tengström; Abigail S Thomas; A Mieke Timmermans; Rob A E M Tollenaar; Melissa A Troester; Christi J van Asperen; Carolien H M van Deurzen; Flora F Van Leeuwen; Laura J Van't Veer; Montserrat García-Closas; Jonine D Figueroa
Journal:  Sci Rep       Date:  2018-04-26       Impact factor: 4.379

9.  PKC and PKA phosphorylation affect the subcellular localization of claudin-1 in melanoma cells.

Authors:  Amanda D French; Jennifer L Fiori; Tura C Camilli; Poloko D Leotlela; Michael P O'Connell; Brittany P Frank; Sarah Subaran; Fred E Indig; Dennis D Taub; Ashani T Weeraratna
Journal:  Int J Med Sci       Date:  2009-03-12       Impact factor: 3.738

10.  Claudin 1 expression in basal-like breast cancer is related to patient age.

Authors:  Anne A Blanchard; Xiuli Ma; Kevin J Dueck; Carla Penner; Steven C Cooper; Drew Mulhall; Leigh C Murphy; Etienne Leygue; Yvonne Myal
Journal:  BMC Cancer       Date:  2013-05-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.